Clinical Trial

Effect of Multitarget tDCS for Neuropathic Pain

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 19, 2024 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to conduct a randomized controlled trial to evaluate the effect of multitarget transcranial direct current stimulation (tDCS) on pain, depression, anxiety, quality of life and sleep, in patients with neuropathic pain.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06510725
Lead Sponsor Xuanwu Hospital, Beijing
Collaborators: Beijing Tiantan Hospital, Second Affiliated Hospital of Tsinghua University
Conditions Neuropathic Pain
Enrollment 200 participants
Start Date 2024-08-01
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-19